Jiangsu Hengrui Medicine Co Ltd (600276) — Cash Flow-to-Debt Ratio
Jiangsu Hengrui Medicine Co Ltd (600276) has a Cash Flow-to-Debt Ratio of 0.58x as of September 2025, meaning its operating cash flow of CN¥4.81 Billion could theoretically repay 1% of its total liabilities (CN¥8.30 Billion) in one year. Explore 600276 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Hengrui Medicine Co Ltd Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Jiangsu Hengrui Medicine Co Ltd across 26 annual periods. Also explore 600276 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jiangsu Hengrui Medicine Co Ltd (1999–2024)
Year-by-year debt coverage analysis for Jiangsu Hengrui Medicine Co Ltd. For market capitalisation and broader financial context, see 600276 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.83x | CN¥7.42 Billion | CN¥4.05 Billion | ▼ -34.0% |
| 2023 | 2.78x | CN¥7.64 Billion | CN¥2.75 Billion | ▲ +765.5% |
| 2022 | 0.32x | CN¥1.27 Billion | CN¥3.94 Billion | ▼ -71.9% |
| 2021 | 1.14x | CN¥4.22 Billion | CN¥3.69 Billion | ▲ +31.2% |
| 2020 | 0.87x | CN¥3.43 Billion | CN¥3.94 Billion | ▼ -40.3% |
| 2019 | 1.46x | CN¥3.82 Billion | CN¥2.62 Billion | ▲ +34.7% |
| 2018 | 1.08x | CN¥2.77 Billion | CN¥2.56 Billion | ▼ -10.9% |
| 2017 | 1.22x | CN¥2.55 Billion | CN¥2.10 Billion | ▼ -31.8% |
| 2016 | 1.78x | CN¥2.59 Billion | CN¥1.46 Billion | ▼ -10.9% |
| 2015 | 2.00x | CN¥2.28 Billion | CN¥1.14 Billion | ▲ +1.2% |
| 2014 | 1.98x | CN¥1.57 Billion | CN¥796.98 Million | ▼ -18.3% |
| 2013 | 2.42x | CN¥1.36 Billion | CN¥564.40 Million | ▲ +13.6% |
| 2012 | 2.13x | CN¥958.37 Million | CN¥450.01 Million | ▲ +77.5% |
| 2011 | 1.20x | CN¥527.36 Million | CN¥439.47 Million | ▲ +30.8% |
| 2010 | 0.92x | CN¥385.95 Million | CN¥420.80 Million | ▼ -30.3% |
| 2009 | 1.32x | CN¥439.12 Million | CN¥333.85 Million | ▲ +157.5% |
| 2008 | 0.51x | CN¥117.46 Million | CN¥229.91 Million | ▼ -11.2% |
| 2007 | 0.58x | CN¥218.87 Million | CN¥380.51 Million | ▼ -56.5% |
| 2006 | 1.32x | CN¥266.18 Million | CN¥201.07 Million | ▲ +2.9% |
| 2005 | 1.29x | CN¥227.88 Million | CN¥177.10 Million | ▲ +58.1% |
| 2004 | 0.81x | CN¥209.41 Million | CN¥257.33 Million | ▲ +225.6% |
| 2003 | 0.25x | CN¥136.82 Million | CN¥547.34 Million | ▲ +97.9% |
| 2002 | 0.13x | CN¥49.84 Million | CN¥394.60 Million | ▲ +296.9% |
| 2001 | 0.03x | CN¥11.49 Million | CN¥361.03 Million | ▼ -49.1% |
| 2000 | 0.06x | CN¥19.61 Million | CN¥313.71 Million | ▼ -44.5% |
| 1999 | 0.11x | CN¥33.89 Million | CN¥301.17 Million | — |